dacarbazine has been researched along with Sarcoma, Epithelioid in 198 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 84 (42.42) | 18.7374 |
| 1990's | 51 (25.76) | 18.2507 |
| 2000's | 32 (16.16) | 29.6817 |
| 2010's | 23 (11.62) | 24.3611 |
| 2020's | 8 (4.04) | 2.80 |
| Authors | Studies |
|---|---|
| Alameda, M; Espinosa, E; Feliu, J; Gallego, A; Gutierrez-Sainz, L; Martinez-Fdez, S; Martinez-Marin, V; Martinez-Recio, S; Mendiola, M; Pedregosa-Barbas, J; Peña, J; Perez-Wert, P; Pertejo-Fernandez, A; Redondo, A; Villamayor, J; Viñal, D; Zamora, P | 1 |
| Blay, JY; Chevreau, C; Czarnecka, AM; D'Ambrosio, L; Duffaud, F; Estival, A; Flippot, R; Gelderblom, H; Grignani, G; Gronchi, A; Kasper, B; Katz, D; Le Cesne, A; Litière, S; Martin-Broto, J; Mazzeo, F; Piperno-Neumann, S; Ray-Coquard, I; Rutkowski, P; Sanfilippo, R; Sents, W; Sherriff, J; Stacchiotti, S; Stark, DP; Tolomeo, F; Touati, N; Tuchscherer, A; Vincenzi, B | 1 |
| Corbellari, R; De Luca, R; Nadal, L; Neri, D; Villa, A | 1 |
| Cabarrou, B; Chevreau, C; Chibon, F; Filleron, T; Le Guellec, S; Lesluyes, T; Lodin, S; Massoubre, A; Mounier, M; Poublanc, M; Valentin, T | 1 |
| D'Ambrosio, L; Gronchi, A; Litière, S; Stacchiotti, S | 1 |
| Pannier, D; Penel, N; Ryckewaert, T | 1 |
| Aristei, C; Biondetti, PR; Cananzi, FCM; Casali, P; Ciccarone, F; Colombo, N; Comandone, A; Corvo', R; De Iaco, P; Dei Tos, AP; Donato, V; Ferrandina, G; Fiore, M; Gadducci, A; Gronchi, A; Guerriero, S; Infante, A; Lorusso, D; Odicino, F; Pirronti, T; Quagliuolo, V; Sanfilippo, R; Scambia, G; Testa, AC; Zannoni, GF | 1 |
| Coleman, RL; Demetri, GD; Herzog, TJ; Hu, P; Jones, RL; Knoblauch, R; McGowan, T; Monk, BJ; Patel, SR; Schuetze, SM; Shalaby, W; Triantos, S; Van Tine, BA; von Mehren, M | 1 |
| Boichuk, SV; Khusnutdinov, RR | 1 |
| Bupathi, M; Chen, JL; Hays, JL | 1 |
| Ahn, JS; Choi, S; Choi, YL; Han, J; Jung, HA; Kim, Y; Lee, J; Lee, SH; Park, K; Sun, JM | 1 |
| Chhabra, L; Sareen, P; Trivedi, N | 1 |
| Bhaumik, G; Chatterjee, K | 1 |
| Manson, SC; Penel, N; Powell, S; Sharma, S; Takyar, S | 1 |
| Motoi, N; Nakano, K; Takahashi, S | 1 |
| Grignani, G; Martín-Broto, J; Reichardt, P; Schuler, M | 1 |
| Komarov, YI; Latipova, DH; Novik, AV; Protsenko, SA; Semenova, AI; Teletaeva, GM | 1 |
| Cousin, S; Penel, N; Peugniez, C | 1 |
| Babre, F; Brouste, V; Henriques de Figueiredo, B; Italiano, A; Kind, M; Le Loarer, F; Michot, A; Rigal, L; Sargos, P; Stoeckle, E; Toulmonde, M | 1 |
| Choti, MA; Pesce, CE; Thornton, K | 1 |
| Bay, JO; Blay, JY; Bui-Nguyen, B; Chevreau, C; Coindre, JM; Cupissol, D; Fargeot, P; Fayette, J; Guillemet, C; Mathoulin-Pelissier, S; Penel, N; Rios, M; Rolland, F; Thyss, A | 1 |
| Akasaka, H; Fujimoto, K; Ito, R; Kitazawa, S; Kodaka, T; Koizumi, N; Kondo, T; Kusama, T; Sakano, S; Takahashi, K; Tsunemine, H; Yamamura, H | 1 |
| Dinter, DJ; Hohenberger, P; Jakob, J; Ströbel, P; Wenz, F | 1 |
| Yang, HJ; Yu, Y; Zong, XY | 1 |
| Bui-Nguyen, B; Italiano, A; Toulmonde, M | 1 |
| Arai, A; Itoh, T; Kanomata, N; Kawamura, A; Kohmura, E; Nishihara, M; Sasayama, T; Tanaka, H | 1 |
| Abdolvahab, F; Brodowicz, T; Dominkus, M; Ebm, C; Fakhrai, N; Jantsch, M; Kauer-Dorner, D; Kostler, WJ; Pokrajac, B; Zielinski, CC | 1 |
| Buesa, JM; Carrasco, JA; Casado, A; Cruz, J; Cubedo, R; de Andrés, R; De Juan, A; Fra, J; García-Del-Muro, X; Gómez-España, A; Laínez, N; López-Pousa, A; Martín, J; Martínez-Trufero, J; Maurel, J; Meana, A; Pericay, C; Poveda, A; Rubió, J | 1 |
| Bay, JO; Blay, JY; Bonichon, F; Bui-Nguyen, B; Chevreau, C; Coindre, JM; Cupissol, D; Italiano, A; Jimenez, M; Lotz, JP; Mathoulin-Pélissier, S; Penel, N; Ray-Coquard, I; Thyss, A | 1 |
| Akiyama, T; Goto, T; Hirata, M; Imanishi, J; Kawano, H; Kobayashi, H; Ogura, K; Okuma, T; Shinoda, Y; Tsuda, Y; Yamamoto, A | 1 |
| Chen, YL; Choy, E; DeLaney, TF; Harmon, DC; Hornicek, FJ; Kobayashi, W; Mullen, JT; Rosenberg, AE; Spiro, IJ; Wang, JJ | 1 |
| Borden, EC; Budd, TG; Elson, P; Hollovary, E; Jacobs, B; Mitsuhashi, M; Spiro, T; Triozzi, P; Yi, T | 1 |
| Issels, RD; Lindner, LH | 1 |
| Chen, YL; Choy, E; DeLaney, TF; Harmon, DC; Hornicek, FJ; Look Hong, NJ; Mullen, JT; Nielsen, GP; Szymonifka, J; Yeap, BY; Yoon, SS | 1 |
| Dei Tos, AP; Del Vescovo, R; Frezza, AM; Santini, D; Schiavon, G; Silletta, M; Tonini, G; Vincenzi, B; Zobel, BB | 1 |
| Birdsell, CA; Crosby, NA; Ernstoff, MS; Poklepovic, A; Ramakrishnan, V; Roberts, JD; Winning, M; Youseffian, L; Youssefian, LE | 1 |
| Cognetti, F; Felici, A; Gelibter, A; Nardoni, C; Serrone, L | 1 |
| Bohlman, M; Duncan, M; Erlich, R; Nicol, T; Olnes, MJ | 1 |
| Bardier, A; Blot, E; Decaudin, D; Pouillart, P; Veyradier, A; Zagame, OL | 1 |
| Kawaguchi, N; Manabe, J; Matsumoto, S; Matsushita, Y; Tanizawa, T | 1 |
| Patel, SR | 1 |
| Hu, L; Huang, YH; Wen, XP | 1 |
| Starkhammar, H; Wall, N | 1 |
| Bell, RS; O'Sullivan, B | 1 |
| Ancukiewicz, M; DeLaney, TF; Gebhardt, MC; Harmon, DC; Hornicek, FJ; Mankin, HJ; Miryousefi, F; Rosenberg, AL; Rosenthal, DI; Spiro, IJ; Suit, HD | 1 |
| Amoateng-Adjepong, Y; Haddad, RG; Upadya, A | 1 |
| Bagiella, E; Hesdorffer, M; Keohan, ML; Orrico, R; Talbot, SM; Taub, RN; Troxel, AB | 1 |
| Bálega, J; Csapó, Z; Demeter, A; Papp, Z; Sipos, N; Szabó, I; Szánthó, A | 1 |
| Beach, J; Benjamin, RS; Burgess, MA; Chen, LL; Papadopolous, N; Patel, SR; Trent, JC | 1 |
| Inoue, H; Kunisada, T; Morimoto, Y; Ohata, N; Ozaki, T; Tanaka, M | 1 |
| Goto, T; Hozumi, T; Kobayashi, H; Kondo, T; Kosaku, H | 1 |
| Buesa, JM; Díaz, A; Esteban, E; Fernández, A; Fra, J; López-Pousa, A; Losa, R; Sierra, M | 1 |
| Bover, I; Buesa, JM; Casado, A; Cruz, J; Garcia del Muro, X; Lopez-Pousa, A; Martin, J; Martinez-Trufero, J; Maurel, J; Poveda, A | 1 |
| Pisters, PW | 1 |
| Blum, RH; DeLaney, TF; Eisenberg, B; Ettinger, DS; Harmon, DC; Harris, J; Kraybill, WG; Letson, GD; Lucas, DR; Spiro, IJ | 1 |
| Buesa, JM; Del Muro, JG; Escudero, P; Esteban, E; Fra, J; Gión, M; Goitia, A; López-Pousa, A; Losa, R; Maurel, J; Nadal, R; Sierra, M; Uña, E | 1 |
| Alberti, L; Blay, JY; Cassier, PA; Dufresne, A; Fayette, J; Ranchere, D; Ray-Coquard, I | 1 |
| Bertuzzi, A; Campagnoli, E; Parra, HJ; Quagliuolo, V; Santoro, A; Zucali, PA | 1 |
| Guan, ZZ; Huang, HQ; Jiang, WQ; Li, FH; Lin, TY; Luo, HY; Qiu, MZ; Sun, XF; Wang, F; Wang, SS; Xu, F; Xu, GC; Xu, RH | 1 |
| Banfi, A; Zanini, M; Zucali, R | 1 |
| Bychkov, MB; Perevodchikova, NI | 1 |
| Briele, HA; Chaudhuri, PK; Das Gupta, TK; Patel, MK | 1 |
| Amiel, JL; Carde, P; Contesso, G; Génin, J; Le Chevalier, T; Rouëssé, J; Sarrazin, D; Sevin, D | 1 |
| Dimitriadis, K; Schmidt, CG; Schütte, J; Seeber, S | 1 |
| Blessing, JA; Creasman, WT; Major, FJ; Omura, GA; Sedlacek, TV; Thigpen, JT; Zaino, RJ | 1 |
| Bramwell, VH; Buesa, J; Mouridsen, HT; Pinedo, HM; Santoro, A; Somers, R; van Oosterom, AT; van Unnik, JA; Vendrik, CP; Wagener, T | 1 |
| Santoro, A; Viviani, S | 1 |
| Ahmann, DL; Burgert, EO; Edmonson, JH; Fleming, TR; Ivins, JC; O'Connell, MJ; Sim, FH; Soule, EH | 1 |
| Biran, S; Pfeffer, MR; Sulkes, A | 1 |
| Di Lauro, L; Lopez, M; Papaldo, P; Perno, CF | 1 |
| Avril, A; Bui, NB; Chauvergne, J; Germain, T; Mage, P; Maree, D; Richaud, P; Trojani, M | 1 |
| Hossfeld, DK; Lempidakis, S; Seeber, S | 1 |
| Adachi, K; Horikoshi, N; Ikeda, K; Inagaki, J; Inoue, K; Nakada, H; Ogawa, M; Okada, Y; Usui, N | 1 |
| Amato, DA; Antman, KH; Blum, RH; Canellos, GP; Corson, JM; Frei, E; Greenberger, JS; Wilson, RE | 1 |
| Baker, LH; Benjamin, RS; Frank, J; Lane, M; Zidar, BL | 1 |
| Clamon, G; Jochimsen, P; Sinkey, C | 1 |
| Karakousis, CP | 1 |
| Barlow, JJ; DeEulis, TG; Lele, SB; Piver, MS | 1 |
| Golbey, RB; Hajdu, SI; Lesser, M; Magill, GB; Shiu, MH; Sordillo, PP | 1 |
| Golbey, RB; Lynch, G; Magill, GB; Sordillo, P | 1 |
| Beretta, G; Fraschini, P; Tedeschi, L | 1 |
| Schepke, P; Wopfner, F | 1 |
| Karakousis, CP; Park, HC; Rao, U | 1 |
| Brunet, R; Bui, B; Chauvergne, J; Durand, M | 1 |
| Bartolucci, AA; Lowenbraun, S; Presant, CA; Smalley, RV | 1 |
| Aroney, RS; Dalley, DN; Fox, RM; Levi, JA; Nesbitt, RA; Tattersall, MH; Woods, RL | 1 |
| Benjamin, RS; Bodey, GP; Burgess, A; Murphy, WK; Rodriguez, V | 1 |
| Hossfeld, DK; Schmidt, CG; Seeber, S; Siemers, E | 1 |
| Baker, LH; Benjamin, RS; Bodey, GP; Bottomley, R; Burgess, MA; Rivkin, SE; Sinkovics, JG; Thigpen, T; Yap, BS | 1 |
| Brunner, KW; Goldhirsch, A; Tièche, M | 1 |
| Blum, RH; Canellos, GP; Corson, JM; Frei, E; Greenberger, JS; Wilson, RE | 1 |
| Demetri, GD; Elias, AD | 1 |
| van Oosterom, AT; Verweij, J | 1 |
| Antoine, E; Brain, E; Fontaine, F; Genin, J; Janin, N; Kayitalire, L; Le Cesne, A; Le Chevalier, T; Spielmann, M; Toussaint, C | 1 |
| Bonichon, F; Bui, BN; Chevallier, B; Chevreau, C; Cupissol, D; Fargeot, P; Krakowski, I; Maugard-Louboutin, C; Peny, AM; Thyss, A | 1 |
| Edmonson, JH | 1 |
| Buesa, J; Casali, P; Mouridsen, H; Rankin, E; Santoro, A; Somers, R; Spooner, D; Steward, W; Tursz, T; Verweij, J | 1 |
| Baker, TR; Hempling, RE; Piver, MS | 1 |
| Greenberg, S; Patsner, B | 1 |
| Bekradda, M; Culine, S; Droz, JP; Terrier-Lacombe, MJ | 1 |
| Brennan, MF; Casper, ES; Gaynor, JJ; Hajdu, SI; Harrison, LB; Panicek, DM | 1 |
| Bramwell, V; Buesa, J; Burgers, M; Priario, J; Rouesse, J; Ruka, W; Santoro, A; Schraffordt-Koops, H; Steward, W; Wagener, T | 1 |
| Bell, R; Catton, C; Cummings, B; Fornasier, V; Hao, Y; LeVay, J; O'Sullivan, B; Quirt, I; Warr, D | 1 |
| Antman, K; Balcerzak, SP; Barlogie, B; Cooper, RM; Crowley, J; Elias, A; Natale, RB; Rivkin, SE; Trump, DL; Weiss, GR | 1 |
| Fernandez de Alava, E; Garcia-Foncillas, J; González-Manzano, R; Herranz, P; Tangco, E; Vieitez, JM | 1 |
| Agarwal, K; Dietel, M; Hossfeld, DK; Schwarz, R; Weh, HJ; Zornig, C | 1 |
| Anagnou, J; Bokemeyer, C; Harstrick, A; Knipp, H; Köhne-Wömpner, CH; Neumann, S; Poliwoda, H; Schmoll, HJ; Schöffski, P; Wipperman, B | 1 |
| Bengala, C; Conte, P; Giannessi, P; Michelotti, A; Romanini, A | 1 |
| Budach, V | 1 |
| Bui, NB; Coindre, JM; Kantor, G; Kind, M; Stöckle, E; Thomas, L | 1 |
| Avril, A; Bui, NB; Bussières, E; Coindre, JM; Kantor, G; Lagarde, P; Marée, D; Stöckle, E; Tramond, P | 1 |
| Boutis, L; Goutzioulis, M; Makedos, G; Papanicolaou, A; Papanicolaou, N; Psikakos, G | 1 |
| Balcerzak, SP; Hicks, LG; Zalupski, M | 1 |
| Kraybill, WG; Valle, AA | 1 |
| Phillips, KA; Toner, GC | 1 |
| Cantor, A; Gieser, P; Green, D; Jenkins, JJ; Marcus, RB; Maurer, HM; Neff, J; Parham, D; Pick, T; Pratt, CB; Rao, BN; Salzberg, A; Thomas, PR | 1 |
| Losardo, P; Pensa, F; Pronzato, P; Tognoni, A | 1 |
| Lévy, E; Piedbois, P; Thirion, P | 1 |
| Bui, BN; Chevallier, B; Chevreau, C; Coindre, JM; Cour-Chabernaud, V; Gil, B; Krakowski, I; Maugard, C; Mihura, J | 1 |
| Buesa, JM; Hermans, C; Judson, I; Lee, SM; Leyvraz, S; Lorigan, PC; Nielsen, OS; Rodenhuis, S; van Glabbeke, M; Verweij, J; Woll, PJ | 1 |
| Bramwell, V; Sawyer, M | 1 |
| Andersson, LC; Blomqvist, CP; Böhling, TO; Huuhtanen, RL; Tribukait, B; Virolainen, MJ; Wiklund, TA | 1 |
| Aoki, I; Kawasaki, C; Kitamura, H; Moriyama, M; Nagashima, Y; Nakamura, N; Nakatani, Y; Okudela, K; Osawa, A | 1 |
| Bangalore, N; Bhargava, P; Hawkins, MJ | 1 |
| Biron, P; Blay, JY; Ray-Coquard, I | 1 |
| Brodowicz, T; Fazeny-Dörner, B; Marosi, C; Muhm, M; Veitl, M; Vogelsang, H; Wenzel, C; Zielinski, C | 1 |
| Cassady, JR; Dritschilo, A; Filler, RM; Green, D; Jaffe, N; Paed, D; Weichselbaum, R | 1 |
| Rosenberg, SA | 1 |
| Ahmann, DL; Bisel, HF; Creagan, ET; Eagan, RT; Edmonson, JH; Hahn, RG | 2 |
| Bramwell, VH; Pinedo, HM; Rosenberg, SA; Voûte, PA | 1 |
| Kenis, Y; Pinedo, HM | 1 |
| Meuret, G | 1 |
| Karrer, K | 1 |
| Grünewald, K; Huber, H | 1 |
| Berger, JL; Friedman, M; Holyoke, ED; Karakousis, CP; Lopez, R; Takita, H | 1 |
| Ayala, A; Krutchik, AN; Sinkovics, JG; Sullivan, C | 1 |
| Kenis, Y; Pinedo, HM; Staquet, M; Sylvester, R; Vendrik, CP | 1 |
| Wobbes, T | 1 |
| Gropp, C; Havemann, K; Schmidt, M; Sodomann, CP | 1 |
| Blumenschein, GR; Buzdar, AU; Krutchik, AN; Sinkovics, JG | 1 |
| Baker, LH; Balcerzak, S; Benjamin, RS; Blumenschein, GR; Bodey, GP; Bottomley, R; Burgess, MA; Coltman, C; Gottlieb, JA; Hoogstraten, B; Moon, TE; O'Bryan, RM; Quagliana, JM; Rivkin, SE; Rodriguez, V; Saiki, JH; Sinkovics, JG; Sullivan, P; Thigpen, T | 1 |
| Azzarelli, A; Bajetta, E; Beretta, G; Bonadonna, G; De Lena, M; Tancini, G; Veronesi, U | 1 |
| Ayala, AG; Goepfert, H; Lindberg, RD; Sinkovics, JG | 1 |
| Baker, LH; Benjamin, RS; Gottlieb, JA; Moon, TE; O'Bryan, RM | 1 |
| Foley, JF; Kessinger, A; Lemon, HM | 1 |
| Gottlieb, JA; Sullivan, MP; Sutow, WW; Wilbur, JR | 1 |
| Eidemiller, LR; Fletcher, WS; Yeager, RA | 1 |
| Klepp, O | 1 |
| Brown, BW; da Cunha, MF; Lipshultz, LI; Meistrich, ML; Wilson, G | 1 |
| Antman, KH | 1 |
| Bokemeyer, C; Harstrick, A; Köhne-Wömpner, CH; Poliwoda, H; Schmoll, HJ; Schöffski, P | 1 |
| Basurto, C; Boschetti, E; Bracarda, S; Del Favero, A; Lupattelli, M; Picciafuoco, M; Roila, F; Sassi, M; Tonato, M | 1 |
| Blomqvist, CP; Elomaa, I; Virolainen, M; Wiklund, TA | 1 |
| Azzarelli, A; Bignami, P; Bonadonna, G; Casali, P; Devizzi, L; Pastorino, U; Quagliuolo, V; Santoro, A; Zucchinelli, P | 1 |
| Broxmeyer, HE; Buescher, ES; Chawla, SP; Cooper, S; Fenoglio, C; Frenck, RW; Hittelman, WN; Holian, A; Papadopoulos, NE; Vadhan-Raj, S | 1 |
| Baan, RA; Keizer, HJ; Ouwerkerk, J; van Delft, JH; van den Ende, AM | 1 |
| Buesa, JM; Mouridsen, HT; Poveda, A; Steward, W; Sylvester, R; Thomas, D; van Oosterom, AT; Verweij, J; Vestlev, PM; Wagener, T | 1 |
| Arzouman, JM; Dudas, S; Ferrans, CE; Holm, K | 1 |
| Benjamin, RS; Lanza, LA; Putnam, JB; Roth, JA | 1 |
| Carpano, S; Conti, EM; Di Lauro, L; Lopez, M; Vici, P | 1 |
| Baker, TR; Caglar, H; Piedmonte, M; Piver, MS | 1 |
| Baker, LH; Balcerzak, S; Benjamin, RS; Bonnet, JD; Chapman, R; Fletcher, WS; Metch, B; Ryan, J; Weiss, GR; Zalupski, M | 1 |
| Antman, KH; Elias, A | 1 |
| Aisner, J; Antman, KH; Elias, A; Ryan, L | 1 |
| Baker, WJ; Fistel, SJ; Jones, RV; Weiss, RB | 1 |
| Dietel, M; Hossfeld, DK; Schwarz, R; Weh, HJ; Wingberg, D; Zornig, C; Zügel, M | 1 |
| Benjamin, RS; Evans, HL; Lorigan, JG; Pezzi, CM; Pezzi, TA; Pollock, RE; Romsdahl, MM | 1 |
| Shinohara, N; Yokoyama, K | 1 |
| Logothetis, CJ; Ro, JY; Samuels, ML; Sella, A; Swanson, DA | 1 |
| Aisner, J; Antman, KH; Collins, J; Elias, A; Ryan, L; Sulkes, A | 1 |
| Beauduin, M; Coster, B; Hermans, J; Majois, F; Schmitz, A; Six, C | 1 |
| Crivellari, D; De Paoli, A; Franchin, G; Frustaci, S; Galligioni, E; Lo Re, G; Monfardini, S; Tumolo, S | 1 |
| Bramwell, V; Eisenhauer, E; Knowling, M; Quirt, I; Verma, S; Warr, D; Young, V | 1 |
| Emrich, LJ; Lele, SB; Marchetti, DL; Piver, MS | 1 |
| Antman, KH; Elias, AD | 2 |
| Avril, A; Bui, NB; Chauvergne, J; Coindre, JM; Hocke, C; Mage, P; Marée, D; Richaud, P; Tramond, P | 1 |
| Bilek, K; Forberg, J; Köhler, U; Richter, R; Spröwitz, M | 1 |
| Benjamin, RS | 1 |
| Baker, LH; Balcerzak, SP; Fine, G; Frank, J; Rivkin, S; Saiki, J; Stephens, RL; Stuckey, WJ; Ward, JH | 1 |
| Kremer, G; Sauer, H; Wilmanns, W | 1 |
| Doutre, LP; Drouillard, J; Soufron, J | 1 |
| Brennan, MF; DeCosse, JJ; Greenall, MJ; Magill, GB | 1 |
| Pinedo, HM; Verweij, J | 1 |
| Amato, DA; Borden, EC; Carbone, PP; Creech, RH; Enterline, HT; Lerner, HJ; Rosenbaum, C; Shiraki, MJ | 1 |
| Ali, MK | 1 |
| Athens, JW; Baker, LH; Balcerzak, SP; Bonnet, JD; Fletcher, WS; Rivkin, SE; Saiki, JH; Shahbender, S | 1 |
| Hartlapp, JH; Illiger, HJ; Jensen, JC; Münch, HJ; Wolter, H | 2 |
| Boutselis, JG; Rose, PG; Sachs, L | 1 |
| Sorbe, B | 1 |
| Borovik, R; Cohen, Y; Haim, N; Kuten, A; Robinson, E; Sapir, D | 1 |
| Coindre, JM; de Mascarel, A; de Mascarel, I; Goussot, JF; Maree, D; Nguyen, BB; Trojani, M | 1 |
| Brunet, R; Bui, NB; Chauvergne, J; Coindre, JM; Durand, M; Hocke, C | 1 |
| Lucas, P; Spielmann, M | 1 |
| Benjamin, R; McKenna, RJ; Meis, J; Mountain, CF; Raymond, AK; Souba, WW | 1 |
| Lele, SB; Patsner, B; Piver, MS | 1 |
26 review(s) available for dacarbazine and Sarcoma, Epithelioid
| Article | Year |
|---|---|
Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic review.
Topics: Antineoplastic Agents; Dacarbazine; Deoxycytidine; Dioxoles; Gemcitabine; Humans; Indazoles; Pyrimidines; Randomized Controlled Trials as Topic; Sarcoma; Sulfonamides; Tetrahydroisoquinolines; Trabectedin; Treatment Failure | 2013 |
Multidisciplinary management of metastatic sarcoma.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Doxorubicin; Humans; Ifosfamide; Lung Neoplasms; Mesna; Sarcoma; Treatment Outcome | 2008 |
[Chemotherapy options for patients with advanced soft-tissue sarcoma beyond anthracyclines].
Topics: Antineoplastic Agents; Dacarbazine; Deoxycytidine; Dioxoles; Docetaxel; Doxorubicin; Gemcitabine; Humans; Ifosfamide; Leiomyosarcoma; Liposarcoma; Sarcoma; Soft Tissue Neoplasms; Taxoids; Tetrahydroisoquinolines; Trabectedin | 2010 |
[Soft-tissue sarcoma: recent developments].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Dacarbazine; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Gemcitabine; Humans; Hyperthermia, Induced; Indazoles; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Pyrimidines; Randomized Controlled Trials as Topic; Sarcoma; Sirolimus; Soft Tissue Neoplasms; Sulfonamides; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Developing therapeutic pharmaceuticals for the treatment of soft-tissue sarcomas.
Topics: Antineoplastic Agents; Benzamides; Camptothecin; Dacarbazine; Deoxycytidine; Dioxoles; Gemcitabine; Humans; Imatinib Mesylate; Irinotecan; Isoquinolines; Piperazines; Pyrimidines; Sarcoma; Temozolomide; Tetrahydroisoquinolines; Trabectedin | 2002 |
[Soft tissue sarcoma: postoperative chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Administration Schedule; Humans; Ifosfamide; Melphalan; Mesna; Methotrexate; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 2004 |
Emerging drugs for the treatment of soft tissue sarcomas.
Topics: Antineoplastic Agents; Benzamides; Dacarbazine; Doxorubicin; Gastrointestinal Stromal Tumors; Humans; Ifosfamide; Imatinib Mesylate; Indoles; Piperazines; Pyrimidines; Pyrroles; Sarcoma; Sunitinib | 2007 |
Chemotherapy of soft tissue sarcomas.
Topics: Antineoplastic Agents; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Humans; Sarcoma; Soft Tissue Neoplasms | 1980 |
Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Humans; Ifosfamide; Mesna; Randomized Controlled Trials as Topic; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Vincristine | 1995 |
New drugs for the treatment of sarcomas.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Administration Schedule; Humans; Ifosfamide; Immunologic Factors; Multicenter Studies as Topic; Nitrosourea Compounds; Organoplatinum Compounds; Randomized Controlled Trials as Topic; Sarcoma; Treatment Outcome; Tubulin Modulators | 1995 |
[Locally developed sarcoma of the thoracic wall].
Topics: Antineoplastic Combined Chemotherapy Protocols; Back; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Doxorubicin; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Mesna; Middle Aged; Neoplasm Invasiveness; Prognosis; Radiotherapy Dosage; Sarcoma; Soft Tissue Neoplasms; Thoracic Neoplasms | 1996 |
Management of soft tissue sarcomas of the extremity in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Extremities; Humans; Methotrexate; Neoplasm Metastasis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms; Vincristine; Wound Healing | 1996 |
Chemotherapy for soft tissue sarcomas. Indications and advances.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Humans; Neoplasm Metastasis; Preoperative Care; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1997 |
[Adjuvant chemotherapy of soft tissue sarcoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Doxorubicin; Follow-Up Studies; Humans; Ifosfamide; Neoplasm Staging; Prognosis; Sarcoma; Soft Tissue Neoplasms; Survival Analysis | 1997 |
The treatment of distant metastases in soft tissue sarcoma.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Doxorubicin; Humans; Ifosfamide; Sarcoma; Soft Tissue Neoplasms | 1999 |
Sustained response of sarcomatoid renal-cell carcinoma to MAID chemotherapy: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Dacarbazine; Doxorubicin; Humans; Ifosfamide; Kidney Neoplasms; Male; Mesna; Middle Aged; Sarcoma; Tomography, X-Ray Computed | 2001 |
[High-dose chemotherapy in soft tissue sarcomas of adults].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dacarbazine; Dioxoles; Dose-Response Relationship, Drug; Doxorubicin; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Isoquinolines; Sarcoma; Tetrahydroisoquinolines; Trabectedin | 2001 |
Chemotherapy of advanced soft-tissue sarcomas in adults.
Topics: Adult; Antineoplastic Agents; Bone Marrow; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Humans; Immunotherapy; Methotrexate; Neoplasm Metastasis; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1977 |
[Therapy of sarcomas].
Topics: Adolescent; Adult; Bone Neoplasms; Child; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Methotrexate; Middle Aged; Osteosarcoma; Remission, Spontaneous; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 1978 |
[Pharmacology of DTIC (author's transl)].
Topics: Animals; Chemical Phenomena; Chemistry; Dacarbazine; Hodgkin Disease; Humans; Melanoma; Sarcoma; Soft Tissue Neoplasms; Triazenes | 1978 |
[Dacarbacine (DTIC) in the therapy of a malignant disease. A review (author's transl)].
Topics: Antineoplastic Agents; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Gastrointestinal Neoplasms; Hodgkin Disease; Humans; Melanoma; Sarcoma; Soft Tissue Neoplasms; Triazenes | 1978 |
Chemotherapy of advanced sarcomas of bone and soft tissue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Humans; Ifosfamide; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms | 1992 |
Chemotherapy of advanced soft-tissue sarcomas.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Drug Evaluation; Humans; Ifosfamide; Random Allocation; Sarcoma; Sarcoma, Kaposi; Soft Tissue Neoplasms | 1988 |
Chemotherapy for soft tissue sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Humans; Lomustine; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1986 |
The treatment of soft tissue sarcomas with focus on chemotherapy: a review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Humans; Hyperthermia, Induced; Ifosfamide; Postoperative Care; Preoperative Care; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1986 |
[Medical treatment of soft-tissue sarcomas in adults].
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Humans; Naphthacenes; Nitrosourea Compounds; Premedication; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1985 |
62 trial(s) available for dacarbazine and Sarcoma, Epithelioid
| Article | Year |
|---|---|
Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Disease-Free Survival; Doxorubicin; Humans; Ifosfamide; Nanotechnology; Neoplasm Grading; Paraffin Embedding; Perioperative Care; Prognosis; Reproducibility of Results; Risk Factors; Sarcoma; Soft Tissue Neoplasms; Transcriptome | 2020 |
Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Ifosfamide; Leiomyosarcoma; Liposarcoma; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Rhabdomyosarcoma; Sarcoma; Survival Rate; Treatment Outcome; Young Adult | 2009 |
Oxaliplatin-dacarbazine combination chemotherapy for the treatment of advanced soft tissue sarcoma of the limbs.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Extremities; Female; Humans; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Sarcoma; Vincristine | 2009 |
Intensified adjuvant IFADIC chemotherapy in combination with radiotherapy versus radiotherapy alone for soft tissue sarcoma: long-term follow-up of a prospective randomized feasibility trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Doxorubicin; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Sarcoma; Treatment Outcome; Young Adult | 2010 |
Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Dacarbazine; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Gastrointestinal Diseases; Gemcitabine; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Spain; Treatment Outcome; Young Adult | 2011 |
High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Consolidation Chemotherapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Mesna; Middle Aged; Peripheral Blood Stem Cell Transplantation; Sarcoma; Young Adult | 2012 |
Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Doxorubicin; Extremities; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Mesna; Middle Aged; Neoadjuvant Therapy; Radiotherapy, Adjuvant; Sarcoma; Survival Rate; Treatment Outcome | 2012 |
Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects.
Topics: Adult; Aged; Antimony Sodium Gluconate; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Colorectal Neoplasms; Dacarbazine; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastrointestinal Stromal Tumors; Humans; Interferon alpha-2; Interferon-alpha; Male; Melanoma; Middle Aged; Phosphoric Monoester Hydrolases; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Recombinant Proteins; Sarcoma; Vinblastine | 2011 |
Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Dacarbazine; Doxorubicin; Extremities; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Mesna; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Sarcoma; Survival Rate; Time Factors; Young Adult | 2013 |
Sorafenib and dacarbazine in soft tissue sarcoma: a single institution experience.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Sarcoma; Sorafenib; Treatment Outcome | 2013 |
Phase I trial of bortezomib and dacarbazine in melanoma and soft tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Dacarbazine; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Medication Adherence; Melanoma; Middle Aged; Pyrazines; Radiography; Sarcoma; Treatment Outcome; Young Adult | 2013 |
[Pilot study of an alternative CYVADIC + CBDCA protocol for adult soft tissue sarcoma as adjuvant chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Humans; Male; Middle Aged; Pilot Projects; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Vincristine | 2002 |
[Preliminary result of advanced soft tissue sarcoma treated by MAID regimen].
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Infusions, Intravenous; Leukopenia; Male; Mesna; Middle Aged; Nausea; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Vomiting | 2002 |
Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Disease-Free Survival; Doxorubicin; Extremities; Female; Humans; Ifosfamide; Male; Mesna; Middle Aged; Neoadjuvant Therapy; Radiotherapy; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome | 2003 |
A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Humans; Leiomyosarcoma; Male; Middle Aged; Prognosis; Sarcoma; Temozolomide; Treatment Outcome; Uterine Neoplasms | 2003 |
A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Prognosis; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Temozolomide; Treatment Outcome | 2003 |
Phase I clinical trial of fixed-dose rate infusional gemcitabine and dacarbazine in the treatment of advanced soft tissue sarcoma, with assessment of gemcitabine triphosphate accumulation.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Deoxycytidine; Dose-Response Relationship, Drug; Female; Floxuridine; Gemcitabine; Humans; Infusions, Intravenous; Leukocytes, Mononuclear; Male; Maximum Tolerated Dose; Middle Aged; Sarcoma; Treatment Outcome | 2004 |
A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma: a study by the Spanish Group for Research on Sarcomas.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Drug Administration Schedule; Female; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Prognosis; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Temozolomide; Treatment Outcome | 2005 |
Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.
Topics: Adult; Aged; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Doxorubicin; Extremities; Female; Humans; Ifosfamide; Male; Mesna; Middle Aged; Neoadjuvant Therapy; Radiotherapy, Adjuvant; Risk Assessment; Sarcoma; Survival Analysis; Treatment Failure; Treatment Outcome | 2006 |
Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas.
Topics: Adult; Aged; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Aspartate Aminotransferases; Dacarbazine; Deoxycytidine; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Gemcitabine; Hematologic Diseases; Humans; Ifosfamide; Infusions, Intravenous; Liver; Lung; Male; Middle Aged; Remission Induction; Sarcoma; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas.
Topics: Adult; Aged; Blood Cell Count; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Probability; Random Allocation; Sarcoma; Uterine Neoplasms; Vomiting | 1983 |
Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Humans; Leukopenia; Male; Middle Aged; Prognosis; Random Allocation; Sarcoma; Soft Tissue Neoplasms; Thrombocytopenia; Vincristine | 1984 |
[Results of chemotherapy of soft tissue sarcoma in adults].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carubicin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Random Allocation; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1984 |
Randomized study of systemic chemotherapy following complete excision of nonosseous sarcomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Sarcoma; Vincristine | 1984 |
Metastatic sarcomas: chemotherapy with adriamycin, cyclophosphamide, and methotrexate alternating with actinomycin D, DTIC, and vincristine.
Topics: Antineoplastic Agents; Bone Neoplasms; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Methotrexate; Neoplasm Metastasis; Pilot Projects; Prognosis; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1981 |
Protected environment - prophylactic antibiotic program for malignant sarcomas: randomized trial during remission induction chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Middle Aged; Probability; Prognosis; Random Allocation; Sarcoma; Vincristine | 1981 |
High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Kidney; Male; Mesna; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Sarcoma | 1995 |
Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Double-Blind Method; Doxorubicin; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematuria; Hemoglobins; Humans; Ifosfamide; Injections, Subcutaneous; Length of Stay; Lenograstim; Leukocyte Count; Male; Mesna; Middle Aged; Nausea; Neutropenia; Platelet Count; Recombinant Proteins; Regression Analysis; Sarcoma; Soft Tissue Neoplasms; Stomatitis | 1995 |
Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Ifosfamide; Leukopenia; Male; Middle Aged; Prognosis; Prospective Studies; Remission Induction; Sarcoma; Survival Analysis; Thrombocytopenia; Vincristine | 1995 |
Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Middle Aged; Sarcoma; Survival Analysis; Treatment Outcome; Uterine Neoplasms; Vincristine | 1995 |
Treatment of sarcomatoid renal cell carcinoma: is there a role for chemotherapy?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Middle Aged; Retrospective Studies; Sarcoma; Vincristine; Vindesine | 1995 |
Preoperative and postoperative adjuvant combination chemotherapy for adults with high grade soft tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Postoperative Care; Preoperative Care; Prospective Studies; Remission Induction; Sarcoma; Survival Rate; Treatment Outcome | 1994 |
Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Vincristine | 1994 |
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Male; Mesna; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome; Urinary Bladder Diseases | 1993 |
Phase II evaluation of doxorubicin, ifosfamide, and dacarbazine plus amphotericin B in the treatment of metastatic soft tissue sarcomas. A pilot study.
Topics: Adolescent; Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Male; Middle Aged; Pilot Projects; Remission Induction; Sarcoma; Soft Tissue Neoplasms; Survival Analysis | 1993 |
Accelerated epirubicin-ifosfamide-dacarbazine regimen in patients with adult soft tissue sarcomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Staging; Neutropenia; Sarcoma; Treatment Outcome | 1996 |
[Postoperative radiotherapy in soft tissue sarcomas of the limbs. Analysis of irradiation volumes and doses in a series of 31 cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Extremities; Female; Follow-Up Studies; Humans; Male; Postoperative Care; Prospective Studies; Radiotherapy Dosage; Sarcoma; Soft Tissue Neoplasms; Time Factors; Vincristine | 1990 |
GM-CSF did not allow doxorubicin dose escalation in the MAID regimen: a phase I trial. A Southwest Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Dacarbazine; Doxorubicin; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Leukopenia; Mesna; Recombinant Proteins; Sarcoma; Treatment Failure | 1996 |
Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: a Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Recurrence; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1998 |
High-dose-intensity combination chemotherapy for advanced sarcomas: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematologic Tests; Humans; Ifosfamide; Infusions, Intravenous; Male; Mesna; Middle Aged; Neutropenia; Pilot Projects; Recombinant Proteins; Sarcoma | 1998 |
Phase I-II trial of intensification of the MAID regimen with support of lenograstim (rHuG-CSF) in patients with advanced soft-tissue sarcoma (STS).
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lenograstim; Male; Mesna; Middle Aged; Recombinant Proteins; Sarcoma; Survival Analysis | 1999 |
Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Humans; Male; Middle Aged; Sarcoma; Survival Analysis; Temozolomide; Treatment Outcome | 1999 |
A comparative clinical trial evaluating the combination of adriamycin, DTIC, and vincristine, the combination of actinomycin D, cyclophosphamide, and vincristine, and a single agent, methyl-CCNU, in advanced sarcomas.
Topics: Adult; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Fibrosarcoma; Hemangiopericytoma; Histiocytoma, Benign Fibrous; Humans; Leiomyosarcoma; Lomustine; Male; Mesothelioma; Neurofibroma; Nitrosourea Compounds; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Triazenes; Vincristine | 1976 |
Chemotherapy of advanced soft-tissue sarcomas in adults.
Topics: Adult; Antineoplastic Agents; Bone Marrow; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Humans; Immunotherapy; Methotrexate; Neoplasm Metastasis; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1977 |
E.O.R.T.C. protocol for the therapy of metastatic soft tissue sarcoma, a randomized trial.
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Research Design; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1977 |
Role of DTIC (NSC-45388) in the chemotherapy of sarcomas.
Topics: Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Humans; Leiomyosarcoma; Neoplasm Metastasis; Sarcoma; Triazenes; Vincristine | 1976 |
Combination chemotherapy with DTIC (NSC-45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin's disease.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Melanoma; Sarcoma; Skin Neoplasms; Soft Tissue Neoplasms; Triazenes | 1976 |
Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Doxorubicin; Humans; Male; Oligospermia; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Sperm Count; Time Factors; Vincristine | 1992 |
Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dexamethasone; Diphenhydramine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Melanoma; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Sarcoma; Vomiting | 1992 |
Ifosfamide, vincristine, doxorubicin and dacarbazine in adult patients with advanced soft-tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Ifosfamide; Male; Mesna; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1992 |
High-dose DTIC in advanced soft-tissue sarcomas in the adult. A phase II study of the E.O.R.T.C. Soft Tissue and Bone Sarcoma Group.
Topics: Adult; Aged; Dacarbazine; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Male; Middle Aged; Remission Induction; Sarcoma; Soft Tissue Neoplasms | 1991 |
Epirubicin and DTIC (EDIC) for advanced soft-tissue sarcomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Epirubicin; Female; Humans; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 1991 |
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 1991 |
Dana-Farber Cancer Institute studies in advanced sarcoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Central Nervous System Diseases; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Heart Diseases; Humans; Ifosfamide; Lung Diseases; Male; Mesna; Middle Aged; Randomized Controlled Trials as Topic; Sarcoma; Survival Analysis; Urologic Diseases | 1990 |
Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Ifosfamide; Male; Mesna; Middle Aged; Remission Induction; Sarcoma; Soft Tissue Neoplasms; Spinal Cord Neoplasms | 1989 |
Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Heart; Humans; Hysterectomy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Random Allocation; Sarcoma; Uterine Neoplasms; Vincristine | 1988 |
Doxorubicin, ifosfamide, and dacarbazine (AID) with mesna uroprotection for advanced untreated sarcoma: a phase I study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Doxorubicin; Drug Evaluation; Female; Humans; Ifosfamide; Male; Mesna; Middle Aged; Sarcoma | 1986 |
Grade 3 nausea, vomiting, and myelosuppression or progressive, metastatic sarcoma?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Humans; Random Allocation; Sarcoma | 1987 |
Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Random Allocation; Sarcoma; Soft Tissue Neoplasms; Statistics as Topic | 1987 |
The treatment of soft tissue sarcomas with focus on chemotherapy: a review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Humans; Hyperthermia, Induced; Ifosfamide; Postoperative Care; Preoperative Care; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1986 |
Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Patient Compliance; Random Allocation; Sarcoma; Soft Tissue Neoplasms | 1987 |
Analysis of a series of sixty soft tissue sarcomas in adults treated with a cyclophosphamide-vincristine-adriamycin-dacarbazine (CYVADIC) combination.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Neoplasm Metastasis; Sarcoma; Soft Tissue Neoplasms; Thrombocytopenia; Vincristine | 1985 |
112 other study(ies) available for dacarbazine and Sarcoma, Epithelioid
| Article | Year |
|---|---|
Efficacy of second and third lines of treatment in advanced soft tissue sarcomas: a real-world study.
Topics: Dacarbazine; Deoxycytidine; Gemcitabine; Humans; Ifosfamide; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms | 2023 |
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Leiomyosarcoma; Male; Middle Aged; Propensity Score; Retrospective Studies; Sarcoma | 2020 |
The immunocytokine L19-TNF eradicates sarcomas in combination with chemotherapy agents or with immune check-point inhibitors.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Dacarbazine; Female; Humans; Immune Checkpoint Inhibitors; Mice; Mice, Inbred BALB C; Recombinant Fusion Proteins; Sarcoma; Trabectedin; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
Reply to Deleterious effect of ifosfamide in leiomyosarcoma: Convergence of weak signals.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Humans; Ifosfamide; Leiomyosarcoma; Propensity Score; Sarcoma | 2020 |
Deleterious effect of ifosfamide in leiomyosarcoma: Convergence of weak signals.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Humans; Ifosfamide; Leiomyosarcoma; Propensity Score; Sarcoma | 2020 |
Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia).
Topics: Adenosarcoma; Anthracyclines; Antineoplastic Agents; Chemotherapy, Adjuvant; Consensus; Dacarbazine; Female; Humans; Hysterectomy; Ifosfamide; Italy; Lymph Node Excision; Neoplasm Staging; Radiotherapy, Adjuvant; Sarcoma; Uterine Neoplasms | 2020 |
Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Cardiovascular Diseases; Child; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dacarbazine; Doxorubicin; Female; Heart; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Polyethylene Glycols; Product Surveillance, Postmarketing; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Stroke Volume; Trabectedin; Ventricular Function, Left; Young Adult | 2021 |
Mechanisms of Sensitivity of Soft Tissue Sarcoma Cells to Temozolomide.
Topics: Cell Line, Tumor; Cellular Senescence; Dacarbazine; Gene Expression Regulation, Neoplastic; Humans; Leiomyosarcoma; O(6)-Methylguanine-DNA Methyltransferase; Sarcoma; Temozolomide; Tumor Suppressor Protein p53 | 2017 |
Temozolomide post pazopanib treatment failure in patients with advanced sarcoma: A case series.
Topics: Adult; Aged; Antineoplastic Agents; Dacarbazine; Disease Progression; Female; High-Throughput Nucleotide Sequencing; Humans; Indazoles; Male; Middle Aged; Pyrimidines; Retrospective Studies; Sarcoma; Sulfonamides; Temozolomide; Treatment Failure; Vascular Endothelial Growth Factor A; Young Adult | 2017 |
Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinoma.
Topics: Adult; Aged; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Neoplasms, Complex and Mixed; Retrospective Studies; Sarcoma; Survival Analysis | 2018 |
Primary undifferentiated spindle-cell sarcoma of sella turcica: successful treatment with adjuvant temozolomide.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Dacarbazine; Diagnosis, Differential; Humans; Male; Pituitary Neoplasms; Sarcoma; Sella Turcica; Temozolomide | 2013 |
Spindle cell sarcoma of the maxillary antrum.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cyclophosphamide; Dacarbazine; Dose Fractionation, Radiation; Doxorubicin; Epistaxis; Humans; Male; Maxillary Sinus Neoplasms; Sarcoma; Vincristine; Vision Disorders | 2012 |
The CYVADIC regimen as a combination chemotherapy treatment option for advanced soft tissue sarcomas originating from the non-extremities.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Sarcoma; Vincristine | 2015 |
Trabectedin clinical cases: use according to indication in diverse clinical scenarios.
Topics: Anthracyclines; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Contraindications; Dacarbazine; Deoxycytidine; Dioxoles; Female; Femoral Neoplasms; Gemcitabine; Humans; Hysterectomy; Ifosfamide; Leiomyosarcoma; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Radionuclide Imaging; Remission Induction; Salvage Therapy; Sarcoma; Sarcoma, Synovial; Soft Tissue Neoplasms; Tetrahydroisoquinolines; Thigh; Tomography, X-Ray Computed; Trabectedin; Treatment Outcome; Uterine Neoplasms | 2015 |
[Systemic therapy of soft tissue sarcomas].
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Deoxycytidine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Ifosfamide; Indazoles; Indoles; Male; Molecular Targeted Therapy; Neoadjuvant Therapy; Niacinamide; Palliative Care; Phenylurea Compounds; Polyethylene Glycols; Pyrimidines; Pyrroles; Radiography; Sarcoma; Sorafenib; Sulfonamides; Sunitinib; Treatment Outcome | 2015 |
Trabectedin is an effective second-line treatment in soft tissue sarcoma patients.
Topics: Dacarbazine; Dioxoles; Disease-Free Survival; Humans; Sarcoma; Tetrahydroisoquinolines; Trabectedin | 2016 |
The risk of postoperative complications and functional impairment after multimodality treatment for limb and trunk wall soft-tissue sarcoma: Long term results from a monocentric series.
Topics: Abdominal Wall; Activities of Daily Living; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Dacarbazine; Doxorubicin; Extremities; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Mesna; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Postoperative Complications; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Thoracic Wall; Torso; Tumor Burden; Young Adult | 2017 |
[A case of sarcomatoid malignant peritoneal mesothelioma responding to combination chemotherapy of cyclophosphamide, vincristine, adriamycin and dacarbazine(CYVADIC)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease Progression; Doxorubicin; Fatal Outcome; Female; Humans; Mesothelioma; Peritoneal Neoplasms; Sarcoma; Tomography, X-Ray Computed; Vincristine | 2009 |
Preoperative intensity-modulated radiotherapy combined with temozolomide for locally advanced soft-tissue sarcoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Dacarbazine; Female; Humans; Male; Middle Aged; Nausea; Postoperative Complications; Prospective Studies; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Remission Induction; Sarcoma; Temozolomide; Tumor Burden; Vomiting | 2009 |
Brain metastasis of undifferentiated sarcoma and response to temozolomide treatment. Case report.
Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Female; Gene Silencing; Humans; Neoplasm Recurrence, Local; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Temozolomide; Tumor Suppressor Proteins | 2010 |
Neoadjuvant and adjuvant chemotherapy with modified mesna, adriamycin, ifosfamide, and dacarbazine (MAID) regimen for adult high-grade non-small round cell soft tissue sarcomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Ifosfamide; Male; Mesna; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Retrospective Studies; Sarcoma; Treatment Outcome | 2013 |
Salvage chemotherapy for advanced sarcoma patients: a single-institution experience survey.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dacarbazine; Deoxycytidine; Gemcitabine; Humans; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome | 2002 |
Interdigitating dendritic cell sarcoma: a rare malignancy responsive to ABVD chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dendritic Cells; Doxorubicin; Female; Humans; Lymph Nodes; Radiography; Sarcoma; Vinblastine | 2002 |
Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency.
Topics: ADAM Proteins; ADAMTS13 Protein; Adenocarcinoma; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; CA-19-9 Antigen; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Esophageal Neoplasms; Fatal Outcome; Female; Humans; Ifosfamide; Jaundice; Metalloendopeptidases; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Paraneoplastic Syndromes; Sarcoma; Thrombocytopenia; von Willebrand Factor | 2002 |
Chemotherapy of soft tissue sarcoma--a clinical evaluation of treatment over ten years.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Gallium; Humans; Ifosfamide; Male; Middle Aged; Palliative Care; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Vinblastine; Vincristine | 2003 |
Has "MAID" made it in the management of high-risk soft-tissue sarcoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Doxorubicin; Extremities; Humans; Ifosfamide; Mesna; Risk Factors; Sarcoma; Soft Tissue Neoplasms | 2003 |
Recurrent bilateral spontaneous pneumothorax complicating chemotherapy for metastatic sarcoma.
Topics: Acute Disease; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chest Tubes; Dacarbazine; Doxorubicin; Dyspnea; Female; Humans; Lung Neoplasms; Middle Aged; Pleurodesis; Pneumothorax; Recurrence; Sarcoma; Thoracic Surgery, Video-Assisted; Thoracostomy; Tibia; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Adjuvant chemotherapy following surgery in the management of uterine sarcomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Middle Aged; Sarcoma; Uterine Neoplasms; Vincristine | 2003 |
Extended total sacrectomy and reconstruction for sacral tumor.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Dacarbazine; Diagnostic Errors; Doxorubicin; Fibula; Follow-Up Studies; Humans; Ifosfamide; Ilium; Internal Fixators; Intervertebral Disc Displacement; Laminectomy; Lumbar Vertebrae; Male; Mesna; Neoadjuvant Therapy; Neoplasm Invasiveness; Radiotherapy, Adjuvant; Recovery of Function; Rhizotomy; Sacrum; Sarcoma; Spinal Neoplasms; Spinal Nerve Roots | 2004 |
Preoperative chemotherapy and split-course radiation therapy for patients with localized soft tissue sarcomas: home run, base hit, or strike out?
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Doxorubicin; Humans; Ifosfamide; Mesna; Meta-Analysis as Topic; Neoadjuvant Therapy; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Sarcoma; Survival Analysis; Treatment Failure; Treatment Outcome | 2006 |
The "old drug" dacarbazine as a second/third line chemotherapy in advanced soft tissue sarcomas.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Sarcoma; Treatment Outcome | 2008 |
[Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Doxorubicin; Extremities; Female; Follow-Up Studies; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Mesna; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Palliative Care; Pelvic Neoplasms; Remission Induction; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Vincristine; Young Adult | 2007 |
Bone and soft tissue sarcomas in the follow-up of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Radiotherapy; Sarcoma; Soft Tissue Neoplasms; Vinblastine; Vincristine | 1983 |
Modern problems of clinical chemotherapy of malignant tumours.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Carubicin; Dacarbazine; Dactinomycin; Drug Therapy, Combination; Female; Humans; Lomustine; Lung Neoplasms; Male; Melanoma; Methylnitrosourea; Neoplasms; Sarcoma; Skin Neoplasms; Soft Tissue Neoplasms; Vincristine | 1980 |
The role of chemotherapy as an adjuvant to surgery in the initial treatment of primary soft tissue sarcomas in adults.
Topics: Adult; Dacarbazine; Doxorubicin; Histiocytoma, Benign Fibrous; Humans; Leiomyoma; Prospective Studies; Sarcoma; Sarcoma, Synovial; Soft Tissue Neoplasms | 1982 |
[Primary chemotherapy in soft tissue sarcomas considered inoperable].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Vinblastine; Vincristine; Vindesine | 1983 |
Experimental basis and clinical experience with non-cross-resistant combinations in solid tumours.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Ehrlich Tumor; Carcinoma, Small Cell; Cell Line; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Etoposide; Humans; Ifosfamide; Male; Naphthacenes; Sarcoma; Teratoma; Testicular Neoplasms; Vinca Alkaloids; Vincristine | 1984 |
Treatment of advanced soft tissue sarcomas with a modified CYVADIC protocol.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Doxorubicin; Hematopoiesis; Humans; Male; Sarcoma; Thrombocytopenia; Vincristine | 1984 |
Alternating combination chemotherapy of advanced soft tissue sarcomas in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Female; Humans; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1984 |
[Uterine sarcoma. Retrospective analysis of a series of 22 cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Leiomyosarcoma; Retrospective Studies; Sarcoma; Uterine Neoplasms; Vincristine | 1984 |
[Chemotherapy of malignant soft tissue tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Humans; Neoplasm Metastasis; Prognosis; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1983 |
[A combination chemotherapy with adriamycin, cyclophosphamide and DTIC (ACD) for advanced adult soft part sarcoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 1984 |
Survival of patients with localized high-grade soft tissue sarcoma with multimodality therapy. A matched control study.
Topics: Adult; Antineoplastic Agents; Child; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasm Staging; Probability; Prognosis; Sarcoma; Soft Tissue Neoplasms | 1983 |
Combination chemotherapy for advanced sarcomas of bone and mesothelioma utilizing rubidazone and DTIC: a Southwest Oncology Group Study.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Bone Neoplasms; Dacarbazine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Male; Mesothelioma; Middle Aged; Sarcoma | 1983 |
High-dose cyclophosphamide and adriamycin with DTIC maintenance for metastatic soft tissue sarcomas.
Topics: Adult; Aged; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Humans; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 1983 |
Combination of modalities in soft tissue sarcomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1982 |
Cyclophosphamide, vincristine, adriamycin, and dimethyl-triazeno imidazole carboxamide (CYVADIC) for sarcomas of the female genital tract.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Genital Neoplasms, Female; Humans; Ovarian Neoplasms; Prospective Studies; Sarcoma; Uterine Neoplasms; Vincristine | 1982 |
Adjuvant chemotherapy of soft-part sarcomas with ALOMAD (S4).
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1981 |
Combination chemotherapy of advanced sarcomas in adults with "CYOMAD" (S7).
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Heart Diseases; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Nausea; Sarcoma; Vincristine; Vomiting | 1982 |
[Superselective arterial tumor angiography and chemotherapy. Preliminary results (author's transl)].
Topics: Adolescent; Adult; Angiography; Bone Neoplasms; Dacarbazine; Doxorubicin; Female; Humans; Male; Sarcoma; Soft Tissue Neoplasms | 1982 |
Combination chemotherapy (CYVADIC) in metastatic soft tissue sarcomas.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1982 |
[Palliative chemotherapy of adult soft tissue sarcomas with an association of cyclophosphamide-vincristine-adriamycine-dacarbazine (CYVADIC) (author's transl)].
Topics: Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1981 |
Cyclical combination chemotherapeutic regimen in adult soft tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 1981 |
[Chemotherapy of soft tissue sarcomas].
Topics: Antineoplastic Agents; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Humans; Prognosis; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1981 |
Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.
Topics: Antineoplastic Agents; Bone Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Humans; Leukopenia; Neoplasm Metastasis; Pilot Projects; Prognosis; Sarcoma; Soft Tissue Neoplasms; Time Factors; Vincristine | 1980 |
[Adjuvant chemotherapy in soft tissue sarcomas].
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Male; Middle Aged; Prognosis; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1980 |
Successful treatment of metastatic sarcomas with cyclophosphamide, adriamycin, and DTIC (CAD).
Topics: Adult; Aged; Alopecia; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 1980 |
Needed: qualitative improvement in antisarcoma therapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Doxorubicin; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunotherapy; Mice; Randomized Controlled Trials as Topic; Sarcoma; Vincristine | 1995 |
Mesna, doxorubicin, ifosfamide, and dacarbazine chemotherapy for ovarian mixed müllerian sarcoma: report of four cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Mesna; Middle Aged; Mixed Tumor, Mullerian; Ovarian Neoplasms; Sarcoma; Treatment Outcome | 1995 |
Outcome and prognostic factors in soft tissue sarcoma in the adult.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Prognosis; Regression Analysis; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Time Factors; Treatment Outcome; Vincristine | 1993 |
Treatment results obtained in metastatic soft-tissue sarcoma with a combination of doxorubicin and dacarbazine or doxorubicin and ifosfamide.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Male; Middle Aged; Remission Induction; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome | 1993 |
A pilot study of rapidly alternating epirubicin/dacarbazine and ifosfamide as first-line therapy for metastatic soft-tissue sarcoma in adults.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Administration Schedule; Epirubicin; Feasibility Studies; Female; Humans; Ifosfamide; Male; Middle Aged; Pilot Projects; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome | 1993 |
[Palliative chemotherapy for metastatic soft-tissue sarcoma in adulthood--the results of a European study of the EORTC. European Organization for Research and Treatment of Cancer].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Doxorubicin; Europe; Humans; Middle Aged; Palliative Care; Prospective Studies; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1996 |
The use of combined chemotherapy for the treatment of advanced sarcoma of the uterus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Middle Aged; Retrospective Studies; Sarcoma; Survival Rate; Uterine Neoplasms; Vincristine | 1996 |
A high proliferation rate measured by cyclin A predicts a favourable chemotherapy response in soft tissue sarcoma patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Division; Cyclin A; Dacarbazine; Disease Progression; Doxorubicin; Female; Humans; Ifosfamide; Male; Mesna; Middle Aged; Prognosis; Prospective Studies; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Vincristine | 1999 |
Chromophobe renal cell carcinoma with sarcomatoid change. A case report.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cadherins; Carcinoma, Renal Cell; Colloids; Coloring Agents; Cyclophosphamide; Dacarbazine; Doxorubicin; Fatal Outcome; Female; Humans; Hydroxides; Immunohistochemistry; Kidney Neoplasms; Mucin-1; Neoplasms, Multiple Primary; Nephrectomy; Organic Chemicals; Sarcoma; Staining and Labeling; Vincristine | 2000 |
Alterations in intestinal permeability following the intensified polydrug-chemotherapy IFADIC (ifosfamide, Adriamycin, dacarbazine).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Intestinal Mucosa; Intestines; Male; Middle Aged; Nausea; Permeability; Sarcoma; Vomiting | 2002 |
The role of radiation therapy in the treatment of soft tissue sarcomas of childhood.
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Infant; Male; Radiotherapy, High-Energy; Remission, Spontaneous; Rhabdomyosarcoma; Sarcoma; Soft Tissue Neoplasms; Time Factors; Vincristine | 1978 |
Future prospects for immunotherapy.
Topics: Animals; BCG Vaccine; Carcinoma, Hepatocellular; Dacarbazine; Guinea Pigs; Humans; Immunotherapy; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Liver Neoplasms; Melanoma; Methotrexate; Mice; Neoplasms; Neoplasms, Experimental; Sarcoma | 1975 |
Adjuvant treatment of soft tissue sarcoma in children and adults.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Dacarbazine; Dactinomycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leucovorin; Methotrexate; Neoplasm Staging; Sarcoma; Soft Tissue Neoplasms; Urogenital Neoplasms; Vincristine | 1978 |
Feasibility of integration of modalities in melanomas and sarcomas.
Topics: BCG Vaccine; Dacarbazine; Estramustine; Humans; Melanoma; Melphalan; Radiotherapy Dosage; Sarcoma; Skin Neoplasms | 1979 |
Chemoimmunotherapy of sarcomatoid renal cell carcinoma.
Topics: Abdominal Neoplasms; Adenocarcinoma; Animals; Antineoplastic Agents; BCG Vaccine; Carcinosarcoma; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Humans; Kidney Neoplasms; Male; Middle Aged; Sarcoma; Tumor Virus Infections; Vincristine; Viral Vaccines | 1978 |
A preliminary study of cyclophosphamide (NSC-26271), adriamycin (NSC-123127), imidazole carboxamide (NSC-45388), and actinomycin D (NSC-3053) with or without MER-BCG in patients with advanced sarcomas.
Topics: Adult; Antineoplastic Agents; BCG Vaccine; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Methanol; Neoplasm Metastasis; Remission, Spontaneous; Sarcoma | 1978 |
Alveolar soft part sarcoma.
Topics: Adult; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Neoplasm Metastasis; Sarcoma; Shoulder; Soft Tissue Neoplasms | 1978 |
[Treatment of metastasising soft-tissue sarcoma with a uniform combination chemotherapy of cyclosphosphamide, vincristin, adriamycin and DTIC ("CyVADIC") (author's transl)].
Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Fibrosarcoma; Humans; Male; Middle Aged; Neoplasm Metastasis; Remission, Spontaneous; Sarcoma; Soft Tissue Neoplasms; Time Factors; Vincristine | 1978 |
Amphotericin B and combination chemotherapy in the treatment of refractory metastatic breast carcinoma and sarcoma.
Topics: Adult; Aged; Amphotericin B; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Sarcoma; Vincristine | 1978 |
Soft-tissue sarcoma of the head and neck after puberty.
Topics: Adult; Aged; Dacarbazine; Dactinomycin; Doxorubicin; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Puberty; Sarcoma; Vincristine | 1977 |
Advances in the chemotherapy of soft tissue sarcomas.
Topics: Adult; Antineoplastic Agents; Child; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Leiomyosarcoma; Neoplasm Metastasis; Remission, Spontaneous; Rhabdomyosarcoma; Sarcoma; Sarcoma, Kaposi; Soft Tissue Neoplasms; Time Factors; Vincristine | 1977 |
Chemotherapy of non-resectable soft tissue sarcomas.
Topics: Adolescent; Adult; Aged; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Sarcoma; Triazenes | 1975 |
Chemotherapy of sarcomas.
Topics: Adolescent; Adult; Child; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Female; Humans; Rhabdomyosarcoma; Sarcoma; Vincristine | 1975 |
Multimodality therapy in the treatment of regionally inoperable melanomas and sarcomas.
Topics: Adult; Aged; BCG Vaccine; Chemotherapy, Cancer, Regional Perfusion; Dacarbazine; Dactinomycin; Female; Humans; Lymphatic Metastasis; Male; Melanoma; Melphalan; Middle Aged; Sarcoma | 1975 |
[Dimethyl-triazeno-imidazol-carboxamide (DTIC)--a new cytostatic agent].
Topics: Dacarbazine; Hodgkin Disease; Humans; Melanoma; Sarcoma; Triazenes | 1975 |
Epirubicin/dacarbazine rapidly alternated with ifosfamide in the treatment of metastatic soft tissue sarcomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Epirubicin; Female; Humans; Ifosfamide; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 1992 |
Epirubicin plus ifosfamide and dacarbazine (EID) in advanced soft tissue sarcomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Epirubicin; Follow-Up Studies; Humans; Ifosfamide; Sarcoma; Soft Tissue Neoplasms | 1992 |
Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cell Division; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Recombinant Proteins; Sarcoma; Time Factors | 1992 |
Determination of N7-methylguanine in DNA of white blood cells from cancer patients treated with dacarbazine.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; DNA; Enzyme-Linked Immunosorbent Assay; Female; Guanine; Humans; Leukocytes; Male; Melanoma; Middle Aged; Sarcoma | 1992 |
Quality of life of patients with sarcoma postchemotherapy.
Topics: Activities of Daily Living; Adaptation, Psychological; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Humans; Life Style; Male; Middle Aged; Personal Satisfaction; Quality of Life; Sarcoma; Soft Tissue Neoplasms; Surveys and Questionnaires | 1991 |
Response to chemotherapy does not predict survival after resection of sarcomatous pulmonary metastases.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Thoracotomy | 1991 |
Prospective trial of cisplatin, adriamycin, and dacarbazine in metastatic mixed mesodermal sarcomas of the uterus and ovary.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Doxorubicin; Female; Humans; Leukocyte Count; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Platelet Count; Prospective Studies; Sarcoma; Survival Rate; Uterine Neoplasms | 1991 |
Mesna, doxorubicin, ifosfamide, dacarbazine (MAID) regimen for adults with advanced sarcoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Evaluation; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Remission Induction; Sarcoma; Survival Rate | 1990 |
Interstitial pneumonitis associated with ifosfamide therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Mesna; Middle Aged; Pulmonary Fibrosis; Sarcoma | 1990 |
Chemotherapy of metastatic soft tissue sarcoma with a combination of adriamycin and DTIC or adriamycin and ifosfamide.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Mesna; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Survival Rate | 1990 |
Preoperative chemotherapy for soft-tissue sarcomas of the extremities.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Doxorubicin; Extremities; Female; Histiocytoma, Benign Fibrous; Humans; Male; Preoperative Care; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1990 |
[Adjuvant chemotherapy of soft tissue sarcoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Administration Schedule; Female; Humans; Infant; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1990 |
Sarcomatoid renal cell carcinoma. A treatable entity.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Humans; Interferons; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Sarcoma; Vincristine | 1987 |
[Soft-tissue sarcomas. Review of 47 patients treated in 10 years in the same institute].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Humans; Radiotherapy Dosage; Retroperitoneal Neoplasms; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1989 |
Retrospective analysis of the CYVADIC regimen in advanced soft tissue sarcomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1989 |
Combination chemotherapy with doxorubicin, dacarbazine, and ifosfamide in advanced adult soft tissue sarcoma. Canadian Sarcoma Group--National Cancer Institute of Canada Clinical Trials Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Remission Induction; Sarcoma; Soft Tissue Neoplasms | 1989 |
[Conservative loco-regional treatment of soft tissue sarcoma in adults after induction chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Sarcoma; Soft Tissue Neoplasms; Vinblastine; Vincristine; Vindesine | 1985 |
[Therapeutic results in uterine sarcoma (1955-1985)].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Ovariectomy; Sarcoma; Uterine Neoplasms; Vincristine | 1988 |
[Toxicity of the CYVADIC modification in patients with soft tissue sarcomas or malignant mesotheliomas].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Metastasis; Pleural Neoplasms; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1987 |
[New approaches to the diagnosis and treatment of retroperitoneal sarcoma. Apropos of 8 cases collected over a 4-year period].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Male; Middle Aged; Retroperitoneal Neoplasms; Sarcoma; Tomography, X-Ray Computed; Vincristine | 1988 |
Right ventricular metastatic sarcoma.
Topics: Dacarbazine; Echocardiography; Electrocardiography; Heart Neoplasms; Heart Ventricles; Humans; Male; Middle Aged; Sarcoma | 1987 |
A useful high-dose intermittent schedule of adriamycin and DTIC in the treatment of advanced sarcomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Drug Administration Schedule; Humans; Sarcoma | 1986 |
Alternatives to CYVADIC combination therapy of soft tissue sarcomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1986 |
Adjuvant therapy for stage I uterine sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Female; Humans; Neoplasm Recurrence, Local; Retrospective Studies; Sarcoma; Uterine Neoplasms; Vincristine | 1987 |
Radiotherapy and/or chemotherapy as adjuvant treatment of uterine sarcomas.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Leiomyosarcoma; Melphalan; Middle Aged; Parity; Postoperative Care; Prognosis; Radiotherapy Dosage; Retrospective Studies; Sarcoma; Uterine Neoplasms; Vincristine | 1985 |
Postirradiation soft tissue sarcoma occurring in breast cancer patients: report of seven cases and results of combination chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Middle Aged; Neoplasms, Radiation-Induced; Radiotherapy; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1985 |
[Histological changes after chemotherapy of soft tissue sarcomas in the adult].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Nucleus; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Male; Middle Aged; Mitosis; Sarcoma; Soft Tissue Neoplasms; Vincristine; Vindesine | 1985 |
Alternatives to CYVADIC-combination therapy of soft tissue sarcomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Evaluation; Female; Humans; Ifosfamide; Male; Middle Aged; Prognosis; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1985 |
Radiation-induced sarcomas of the chest wall.
Topics: Adolescent; Adult; Aged; Dacarbazine; Female; Humans; Male; Middle Aged; Neoplasms, Radiation-Induced; Prognosis; Radiotherapy; Sarcoma; Thoracic Neoplasms; Thorax | 1986 |
cis-Diamminedichloroplatinum plus dimethyl-triazenoimidazole carboxamide as second- and third-line chemotherapy for sarcomas of the female pelvis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Drug Evaluation; Female; Humans; Neoplasm Metastasis; Pelvic Neoplasms; Sarcoma | 1986 |